BioCentury
ARTICLE | Company News

Teva, Novartis deal

August 4, 2014 7:00 AM UTC

Teva granted Novartis’ Sandoz Inc. generics unit rights to market 100 and 200 mg dosage strengths of a generic version of Teva’s sleep disorder drug Nuvigil armodafinil 180 days after Actavis plc (N...